Abstract
To assess a possible association between antiretroviral treatment and paronychia, we conducted a retrospective cohort study of 288 human immunodeficiency virus-positive protease inhibitor recipients. Indinavir treatment - adjusted for age, sex, CD4 count, diabetes status and other antiretroviral drug exposures - was significantly associated with paronychia of the great toe (hazard ratio 4.7; 95% confidence interval 1.6-13.9).
Original language | English (US) |
---|---|
Pages (from-to) | 140-143 |
Number of pages | 4 |
Journal | Clinical Infectious Diseases |
Volume | 32 |
Issue number | 1 |
DOIs | |
State | Published - 2001 |
Externally published | Yes |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases